Gilead Sciences, Inc. entered into a Ninth Supplemental Indenture for the issuance of $1 billion aggregate principal amount of 5.250% Senior Notes due 2033 and $1 billion aggregate principal amount of 5.550% Senior Notes due 2053.
AI Assistant
GILEAD SCIENCES INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.